|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61P 43/00 | (2018.01) | ||
| A61K 38/095 | (2019.01) | ||
| A61P 5/10 | (2018.01) | ||
| A61K 38/12 | (2006.01) | ||
| A61P 1/14 | (2018.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/183 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61P 25/24 | (2018.01) | ||
| A61P 15/04 | (2006.01) | ||
| A61K 38/095 | (2019.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 15/04 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61K 38/12 | (2013.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 15/08 | (2018.01) | ||
| A61P 19/10 | (2018.01) | ||
| A61P 25/22 | (2018.01) | ||
| A61P 15/14 | (2018.01) | ||
| A61P 15/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 1/10 | (2018.01) | ||
| A61P 7/04 | (2018.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 17/02 | (2018.01) | ||
| A61P 25/18 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 15/10 | (2018.01) | ||
| A61P 7/06 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61K 9/0043 | (2013.01) | ||
| A61K 9/0019 | (2013.01) | ||
| A61K 47/20 | (2013.01) |
| (11) | Number of the document | 3246018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17169301.3 |
| Date of filing the European patent application | 2011-09-29 | |
| (97) | Date of publication of the European application | 2017-11-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 10251690 | 2010-09-30 | EP |
| (72) |
NILSSON, Anders , SE
MALM, Mattias , DK
WISNIEWSKI, Kazimierz , US
SIEKMANN, Britta , SE
|
| (73) |
Ferring B.V. ,
Polaris Avenue 144, 2132 JX Hoofddorp,
NL
|
| (54) | PHARMACEUTICAL COMPOSITION |
| PHARMACEUTICAL COMPOSITION |